Full Text View
Tabular View
No Study Results Posted
Related Studies
Baclofen Treatment of Ataxia Telangiectasia
This study is currently recruiting participants.
Study NCT00640003.   Last updated on March 19, 2008.
Information provided by Johns Hopkins University
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ataxia Telangiectasia (A-T)
Additional conditions recognized in this trial
Ataxia
Ataxia Telangiectasia
Telangiectasis
More general conditions related to this trial
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebellar Ataxia
Cerebellar Diseases
DNA Repair-Deficiency Disorders
Dyskinesias
Genetic Diseases, Inborn
Immune System Diseases
Immunologic Deficiency Syndromes
Metabolic Diseases
Nervous System Diseases
Neurocutaneous Syndromes
Neurologic Manifestations
Signs and Symptoms
Spinocerebellar Ataxias
Vascular Diseases
Interventions listed in this trial
Baclofen or Placebo
Additional drug interventions recognized in this trial
Baclofen
More general drug interventions related to this trial
Central Nervous System Agents
GABA Agents
GABA Agonists
Molecular Mechanisms of Pharmacological Action
Muscle Relaxants, Central
Neuromuscular Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Johns Hopkins University


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services